TUBERCULOSIS RESOURCES

Where we unite to #EndTB!

​​​​​​​​​​​​​​​​​TB GUIDES

Una Guia Para Activistas Sobre Herramientas De Diagnostico De La Tuberculosis [An Activist’s Guide to Tuberculosis Diagnostic Tools]


Preventing Tuberculosis in Your Clinical Setting: A Practical Guidebook


Management of Drug-Resistant Tuberculosis in Pregnant and Peripartum People: A FIELD GUIDE


Guidance for national strategic planning for tuberculosis


Tuberculosis: Clinical Policies and Program Manual


Preventing TB in Your Clinical Setting- A Practical Guidebook


NTCA Provider Guidance: A 4-Month Regimen to Treat Pulmonary Tuberculosis: Isoniazid, Rifampin, Moxifloxacin, and Pyrazinamide (HPMZ).


WHO announces updates on its guidance on tuberculosis care and support


WHO operational handbook on tuberculosis: module 4: treatment: tuberculosis care and support


WHO consolidated guidelines on tuberculosis: module 4: treatment: tuberculosis care and support


Cultural Quick Reference Guide: Ukraine


Uniting for Ukraine: Information for TB Programs


Clinical standards for drug-susceptible pulmonary TB


​TB Language Guide 2.0 launched at Stop TB Partnership Board meeting


Provisional CDC Guidance for the Use of Pretomanid as part of a Regimen [Bedaquiline, Pretomanid, and Linezolid (BPaL)] to Treat Drug-Resistant Tuberculosis Disease


Severe COVID-19: A TB Risk Factor


WHO Consolidated Guidelines on Tuberculosis, Module 4: Treatment - Drug-Susceptible Tuberculosis Treatment


Human rights, informed consent, and high ethical standards as a basis for people-centered TB care


Tuberculosis prevention and care among refugees and other populations in humanitarian settings: an interagency field guide


​Manual for selection of molecular WHO recommended rapid diagnostic tests for detection of tuberculosis and drug-resistant tuberculosis


Practical manual of processing stool samples for diagnosis of childhood TB


Line probe assays for detection of drug-resistant tuberculosis: interpretation and reporting manual for laboratory staff and clinicians


WHO issues Information Note on ensuring continuity of essential TB services for people with or at risk of the disease in Ukraine and refugee-hosting countries


Virtual Meeting of the Global Multisectoral and Multi-stakeholder Platform to end TB


How to Treat Drug-Resistant Tuberculosis


​Community-led Monitoring for Access to Tuberculosis Screening and Diagnostic Testing


Tuberculosis in the time of COVID-19


Community-led Monitoring for Access to Tuberculosis Screening and Diagnostic Testing


​Testing for tuberculosis infection and screening for tuberculosis disease among refugees arriving in European countries from Ukraine


Optimized broth microdilution plate methodology for drug susceptibility testing of Mycobacterium tuberculosis complex


Managing Drug Interactions in HIV and TB Coinfection Is Complex


Information sheet: Management of tuberculosis in children and adolescents


WHO operational handbook on tuberculosis Module 5: Management of tuberculosis in children and adolescents


WHO consolidated guidelines on tuberculosis Module 5: Management of tuberculosis in children and adolescents


An Activist’s Guide to Rifapentine for the Treatment of TB Infection


Clinical standards for the diagnosis, treatment and prevention of TB infection


Interim Guidance: 4-Month Rifapentine-Moxifloxacin Regimen for the Treatment of Drug-Susceptible Pulmonary Tuberculosis — United States, 2022


TB Provider Toolkit


Clinical standards for the diagnosis, treatment and prevention of TB infection


​Building Resilience: Keeping Mentally Healthy to Keep Moving Forward


New American Academy of Pediatrics statement on testing for and treating TB infection in children: Tuberculosis Infection in Children and Adolescents: Testing and Treatment


​The Mantoux Tuberculin Skin Test Wall Chart


CDC - Patient Education Materials Series​


CDC - Tuberculosis: The Connection between TB and HIV


CULTURAL QUICK REFERENCE GUIDE: AFGHANISTAN